2025-11-17T11:50:41-06:00 2024-12-31 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2024-01-01 981051444 GLOBAL HEALTH INVESTMENT CORPORATION GLOB 6467751981 500 FIFTH AVENUE SUITE 4000 NEW YORK NY 10110 EVELYN YANATOS TREASURER 6467751981 2025-11-17 1 1 WILLIAM EPSTEIN P01307171 2129498700 2024 2025-03-06 01:10:19Z LABEEB ABBOUD 500 FIFTH AVENUE SUITE 5120 NY NY 10010 27759830 0 X WWW.GHICFUNDS.ORG X 2012 DE THE CORPORATION IS ORGANIZED AND SHALL BE OPERATED EXCLUSIVELY FOR SOCIAL (CONTINUED SCHEDULE O) (CONTINUED FROM FORM 990, PAGE 1 PART I) WELFARE PURPOSES WITHIN THE MEANING OF SECTION 501(C)(4) OF THE INTERNAL REVENUE CODE OF 1986, AS IT BE AMENDED, INCLUDING THE RELIEF OF THE POOR AND DISTRESSED OR OF THE UNDERPRIVILEGED; THE PROMOTION OF SOCIAL WELFARE AND THE LESSENING OF THE BURDENS OF GOVERNMENT. IN FURTHERANCE OF THESE PURPOSES, THE CORPORATION MAY SEEK WAYS TO PROVIDE AFFORDABLE FINANCING TO SUPPORT THE DEVELOPMENT OF THERAPEUTIC DRUGS & TREATMENTS, VACCINES, PREVENTATIVES, DIAGNOSTICS, AND OTHER TECHNOLOGIES, PRODUCTS OR SERVICES TO ADDRESS GLOBAL HEALTH CHALLENGES, INCLUDING WITHOUT LIMITATION, SUPPORTING THE DEVELOPMENT OF MEDICAL COUNTERMEASURES AND TECHNOLOGIES THAT CAN HELP ADDRESS THREATS TO GLOBAL HEALTH SECURITY, ALL TO PROMOTE THE SOCIAL WELFARE OF ALL POPULATIONS. 4 3 14 0 0 0 198507541 10398500 50000 3648414 5362261 14237388 174475 -524472 204094277 27759830 0 0 0 0 2828711 4581153 0 0 0 1524092 2266067 4352803 6847220 199741474 20912610 365650768 376715238 7244654 13980173 358406114 362735065 X THE MISSION OF THE GLOBAL HEALTH INVESTMENT CORPORATION IS TO CATALYZE THE DEVELOPMENT OF TECHNOLOGIES TO IMPROVE GLOBAL HEALTH AND HEALTH, AND STRENGTHEN GLOBAL HEALTH SECURITY. THE ORGANIZATION SEEKS TO ADVANCE ITS MISSION BY (CONTINUED SCHEDULE O) 0 0 5477776 3648414 IN APRIL 2024, THE GLOBAL HEALTH INVESTMENT CORPORATION (GHIC) HELD THE INITIAL CLOSING OF THE GLOBAL HEALTH SECURITY FUND, L.P. (GHSF) WITH A TOTAL OF $272.589 MILLION IN SUBSCRIPTIONS BY EIGHT INVESTORS, INCLUDING $175 MILLION FROM GHIC SLP, LLC USING FUNDING PROVIDED BY BARDA. AS PART OF THE INITIAL CLOSING, GHIC SLP, LLC CONTRIBUTED TO GHSF ALL ITS INVESTMENTS MADE TO DATE, WHICH CONTRIBUTION FULFILLED IN PART THE CAPITAL COMMITMENTS TO GHSF OF MITRE AND OF GHIC SLP, LLC. AS OF THE END OF 2024, GHSF HAD DEPLOYED $85.4 MILLION IN TOTAL OF ITS INVESTMENT CAPITAL, INCLUDING THOSE INVESTMENTS CONTRIBUTED TO GHSF AT INITIAL CLOSING AND INVESTMENTS MADE SINCE INITIAL CLOSING. (CONTINUED SCHEDULE O) (CONTINUED FROM PART III, 4A) AS PART OF THE INITIAL CLOSING OF GHSF, GHIC MADE ITS FIRST FUND INVESTMENT UNDER ITS CATALYTIC HEALTH INVESTMENT PLATFORM (CHIP), FUNDED BY THE GERMAN GOVERNMENT AFFILIATED DEVELOPMENT BANK KFW, BY COMMITTING $10 MILLION TO GHSF. IN SEPTEMBER 2024, GHIC MADE ITS SECOND FUND INVESTMENT UNDER CHIP BY COMMITTING $5 MILLION TO TRANSFORM HEALTH FUND LLC USING FUNDS PROVIDED BY KFW. IN DECEMBER 2024, KFW AGREED TO INCREASE THE FUNDS AVAILABLE UNDER CHIP FROM 30.5 MILLION TO 40.5 MILLION.ALSO IN 2024, GHIC PUBLICLY ANNOUNCED THE COMMENCEMENT OF THE "FRONTIER FUND," AN INITIATIVE TO IDENTIFY AND ACCELERATE HIGH-POTENTIAL TRANSLATIONAL RESEARCH THROUGH NON-DILUTIVE FUNDING, FUNDED WITH $20 MILLION GRANTED TO THE GHIC BY THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE'S BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY ("BARDA") UNDER AN OTHER TRANSACTION AGREEMENT ("OTA"), AND SELECTED ITS FIRST TWO AWARD RECIPIENTS FOR FUNDING UNDER THE FRONTIER FUND. 5477776 0 1 0 0 0 0 0 0 0 0 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 X 20 0 14 0 0 0 0 0 0 0 0 0 0 0 X 4 3 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 X EVELYN YANATOS 5164486106 500 FIFTH AVENUE 40TH FLOOR NEW YORK NY 10110 LABEEB M ABBOUD CHAIRMAN AND CEO 40.00 0.00 X X 919886 0 125516 ARLINA ELMIGER DIRECTOR 1.00 0.00 X 0 0 0 PAUL KLINGENSTEIN DIRECTOR 1.00 0.00 X 25000 0 0 GEORGE W WELLDE JR DIRECTOR 1.00 0.00 X 25000 0 0 SHUENN HO BEG MARCH 2024 HEAD OF LEGAL AND SECRETARY 40.00 0.00 X 245672 0 69418 EVELYN YANATOS TREASURER 10.00 0.00 X 132000 0 0 OLAYINKA FAGBAYI VICE PRESIDENT 40.00 0.00 X 380480 0 64787 JOSEPH LEE PRINCIPAL 40.00 0.00 X 278614 0 39801 CHARLES JEFFREY PETTY MANAGING DIRECTOR 40.00 0.00 X 581862 0 87335 DEVIN SOK BEG MAY 2024 HEAD OF SCIENCE 40.00 0.00 X 199435 0 20712 2787949 0 407569 7 0 1 0 FOLEY AND LARDNER LLP 555 SOUTH FLOWER STREET STE 3300 LOS ANGELES CA 90071 LEGAL 155997 EBY ENTERPRISES 315 EAST 70TH STREET 12M NEW YORK NY 10021 OUTSOURCE ACCOUNTING AND CONSULTING 132000 2 10398500 10398500 MANAGEMENT AND ADVISOR 900099 3648414 3648414 3648414 14237388 14237388 FOREIGN EXCHANGE LOSS 900099 -524472 -524472 -524472 27759830 3648414 0 13712916 1227402 981922 245480 2587112 2069690 517422 401301 321040 80261 192061 153650 38411 173277 138622 34655 344238 275390 68848 151376 121101 30275 666278 533022 133256 2224 1779 445 98399 78719 19680 385864 308692 77172 128984 103187 25797 342411 273929 68482 9269 7415 1854 125194 100155 25039 DUES AND SUBSCRIPTIONS 10653 8522 2131 0 UTILITIES 1177 941 236 0 6847220 5477776 1369444 0 280386887 290155446 102927 42922 51939 84507975 85674837 712984 730089 365650768 376715238 565053 806820 6679601 13173353 7244654 13980173 X 38268412 27415674 320137702 335319391 358406114 362735065 365650768 376715238 20912610 -16583659 0 X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 GLOBAL HEALTH INVESTMENT FUND 10889913 F ADJUVANT GLOBAL HEALTH TECHNOLOGY 11858375 F WOMEN'S AND CHILDREN'S HEALTH TECHNOLOGY EU FUND SCSP 2737062 F TRANSFORM HEALTH FUND LLC 670973 F GLOBAL HEALTH SECURITY FUND - BARDA 56304675 F GLOBAL HEALTH SECURITY FUND - KFW 3213839 F 85674837 DUE TO INVESTOR 13105952 DUE TO GLOBAL HEALTH SECURITIES FUND 67401 13173353 X 11176171 -16583659 -16583659 27759830 0 27759830 6847220 0 6847220 0 6847220 PART X, LINE 2: THE CORPORATION IS SUBJECT TO THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARD CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, AS IT RELATES TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME-TAX OBLIGATIONS. FOR THE CORPORATION, THESE PROVISIONS COULD BE APPLICABLE TO THE INCURRENCE OF UNRELATED BUSINESS INCOME. BECAUSE OF THE CORPORATION'S GENERAL TAX EXEMPT STATUS, MANAGEMENT BELIEVES ASC TOPIC 740 HAS NOT HAD, AND IS NOT ANTICIPATED TO HAVE, A MATERIAL IMPACT ON THE CORPORATION'S CONSOLIDATED FINANCIAL STATEMENTS. X X X X X 0 1 0 0 0 0 0 1 0 LABEEB M ABBOUD CHAIRMAN AND CEO 642600 0 275000 0 2286 0 65000 0 60516 0 1045402 0 0 0 CHARLES JEFFREY PETTY MANAGING DIRECTOR 441700 0 140000 0 162 0 45000 0 42335 0 669197 0 0 0 OLAYINKA FAGBAYI VICE PRESIDENT 320300 0 60000 0 180 0 32500 0 32287 0 445267 0 0 0 JOSEPH LEE PRINCIPAL 234470 0 44000 0 144 0 24000 0 15801 0 318415 0 0 0 SHUENN HO BEG MARCH 2024 HEAD OF LEGAL AND SECRETARY 235550 0 10000 0 122 0 24375 0 45043 0 315090 0 0 0 DEVIN SOK BEG MAY 2024 HEAD OF SCIENCE 194354 0 5000 0 81 0 19755 0 957 0 220147 0 0 0 PART I, LINE 3 COMPENSATION FOR THE ORGANIZATION'S CEO HAS BEEN DETERMINED USING INDEPENDENT COMPENSATION CONSULTANTS, REVIEW OF FORMS 990 FROM COMPARABLE ORGANIZATIONS, VERIFIED AGAINST INDUSTRY COMPENSATION SURVEYS AND APPROVED BY THE BOARD THROUGH A WRITTEN EMPLOYMENT CONTRACT. THE PRECEDING MAY BE DONE FROM TIME TO TIME AS NEEDED. COMPENSATION FOR THE ORGANIZATION'S MANAGING DIRECTOR LEVELS AND INDEPENDENT BOARD MEMBERS HAS BEEN DETERMINED USING INDEPENDENT COMPENSATION CONSULTANTS, REVIEW OF FORMS 990 FROM COMPARABLE ORGANIZATIONS, VERIFIED AGAINST INDUSTRY COMPENSATION SURVEYS AND APPROVED BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. THE PRECEDING MAY BE DONE FROM TIME TO TIME AS NEEDED. PART I, LINE 4B THERE IS A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN FOR CERTAIN OFFICERS OF THE ORGANIZATION. PART I, LINE 7 LONG-TERM COMPENSATION PROGRAM: THE ORGANIZATION RECOGNIZES THE INVALUABLE CONTRIBUTION OF ITS CURRENT SENIOR MANAGEMENT TEAM TO ITS ACHIEVEMENTS THUS FAR. IN ORDER TO ENSURE THE RETENTION OF THIS TALENTED TEAM AND TO FOSTER THE ATTRACTION AND DEVELOPMENT OF FUTURE LEADERS, THE ORGANIZATION HAS IMPLEMENTED A COMPREHENSIVE COMPENSATION PROGRAM. THIS PROGRAM IS METICULOUSLY CRAFTED TO: (I) ALIGN REMUNERATION WITH PERFORMANCE METRICS TIED TO THE ORGANIZATION'S STRATEGIC PLAN AND OVERARCHING OBJECTIVES. (II) OFFER A COMPETITIVE COMPENSATION PACKAGE, COMPRISING BASE PAY, BONUSES, AND LONG-TERM INCENTIVES, COMMENSURATE WITH ORGANIZATIONS OF SIMILAR PROFILE. AS SUCH, THE ORGANIZATION'S COMPENSATION FRAMEWORK IS STRUCTURED TO (I) DRIVE AND INCENTIVIZE PRESENT HIGH-PERFORMANCE STANDARDS, (II) ACKNOWLEDGE AND REWARD THE EXPERTISE AND TENURE OF OUR TEAM MEMBERS, AND (III) PROVIDE LONG-TERM INCENTIVES AIMED AT RETAINING KEY MANAGEMENT PERSONNEL. FORM 990, PART I, LINE 5, & PART V, LINE 2A AND B THE ORGANIZATION USES A PROFESSIONAL EMPLOYER ORGANIZATION (PEO) FOR THE FILING OF FORM W-2. AS SUCH, THE ORGANIZATION ITSELF DOES NOT ISSUE ANY FORMS W-2 USING ITS EIN. THE ORGANIZATION DOES, HOWEVER, HAVE 8 EMPLOYEES WHO RECEIVE W-2'S THROUGH THE PEO PAYMASTER. THE ORGANIZATION ENSURES THAT THE PEO FILES ALL REQUIRED FEDERAL EMPLOYMENT TAX RETURNS. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS THREE DIRECTOR MEMBERS WITH EQUAL VOTING RIGHTS. THEY HAVE THE POWER TO ELECT OR APPOINT OTHER DIRECTOR MEMBERS. FORM 990, PART VI, SECTION A, LINE 7A THE ORGANIZATION HAS THREE DIRECTOR MEMBERS WITH EQUAL VOTING RIGHTS. THEY HAVE THE POWER TO ELECT OR APPOINT OTHER DIRECTOR MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THIS FORM WAS REVIEWED AND APPROVED BY THE ORGANIZATION'S BOARD OF DIRECTOR'S AUDIT COMMITTEE, WHICH PERFORMS THIS FUNCTION ON BEHALF OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 12C THESE DETAILS ARE DISCUSSED AT PERIODIC BOARD AND OTHER MEETINGS THROUGHOUT THE YEAR. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION FOR THE ORGANIZATION'S CEO HAS BEEN DETERMINED USING INDEPENDENT COMPENSATION CONSULTANTS, REVIEW OF FORMS 990 FROM COMPARABLE ORGANIZATIONS, VERIFIED AGAINST INDUSTRY COMPENSATION SURVEYS AND APPROVED BY THE BOARD THROUGH A WRITTEN EMPLOYMENT CONTRACT. THE PRECEDING MAY BE DONE FROM TIME TO TIME AS NEEDED. COMPENSATION FOR THE ORGANIZATION'S MANAGING DIRECTOR LEVELS AND INDEPENDENT BOARD MEMBERS HAS BEEN DETERMINED USING INDEPENDENT COMPENSATION CONSULTANTS, REVIEW OF FORMS 990 FROM COMPARABLE ORGANIZATIONS, VERIFIED AGAINST INDUSTRY COMPENSATION SURVEYS AND APPROVED BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. THE PRECEDING MAY BE DONE FROM TIME TO TIME AS NEEDED. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICIES AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST TO OUR MEMBERS AND THE PUBLIC AT LARGE. GHIC SLP LLC 500 FIFTH AVENUE SUITE 4000 NY NY 10010 882361986 SEE SCHED R SUP INFO DE -612079 56304675 GLOBAL HEALTH INVESTMENT CORPORATION GHIC ADVISORS LLC 500 FIFTH AVENUE SUITE 4000 NY NY 10010 SEE SCHED R SUP INFO DE 0 0 GLOBAL HEALTH INVESTMENT CORPORATION GHSF GP LLC 500 FIFTH AVENUE SUITE 4000 NY NY 10010 SEE SCHED R SUP INFO DE 0 0 GLOBAL HEALTH INVESTMENT CORPORATION GHIC CHIP SPV LLC 500 FIFTH AVENUE SUITE 4000 NY NY 10010 SEE SCHED R SUP INFO DE 0 0 GLOBAL HEALTH INVESTMENT CORPORATION GHIC HOLDINGS I LLC 500 FIFTH AVENUE SUITE 4000 NY NY 10010 SEE SCHED R SUP INFO DE 0 0 GLOBAL HEALTH INVESTMENT CORPORATION GLOBAL HEALTH INVESTMENT FUND 500 FIFTH AVENUE SUITE 4000 NY NY 10010 981051448 INVESTMENT FUND FOR GLOBAL HEALTH RESEARCH DE GLOBAL HEALTH INVESTMENT CORPORATION STATUTORILY EXEMPT -34976 3213839 0 1 0.12240 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 GHIC GLOBAL HEALTH SECURITY PORTFOLIO LLC B FV GLOBAL HEALTH INVESTMENT FUND C FV ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE LP 501 5TH AVE SUITE 1404 NY NY 10017 832182505 INVESTMENT FUND FOR GLOBAL HEALTH RESEARCH DE STATUTORILY EXEMPT 0 11858375 0 0 0.46220 WOMEN'S AND CHILDREN'S HEALTH TECHNOLOGY EU FUND SCSP 501 5TH AVE SUITE 1404 NY NY 10017 INVESTMENT FUND FOR GLOBAL HEALTH RESEARCH DE STATUTORILY EXEMPT 0 2737062 0 0 0.14850 TRANSFORM HEALTH FUND LLC 501 5TH AVE SUITE 1404 NY NY 10017 INVESTMENT FUND FOR GLOBAL HEALTH RESEARCH DE STATUTORILY EXEMPT 0 670973 0 0 SCHEDULE R, PART 1, COLUMN B - PRIMARY ACTIVITY LIMITED LIABILITY COMPANIES ESTABLISHED AS VEHICLES THROUGH WHICH GHIC WOULD MAKE INVESTMENTS IN A PORTFOLIO OF BIOTECHNOLOGY COMPANIES TO SUPPORT GLOBAL HEALTH RESEARCH AND DEVELOPMENT.